IP Library › Assignment 038413/0725
Patent Assignment
Reel/Frame 038413/0725

Assignment of Assignor's Interest

Recorded: 2016-04-28 Pages: 4
Assignor
ALNYLAM EUROPE AG
Executed: 2009-08-05
Assignee
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties (3)
Compositions and Methods For Inhibiting Expression Of A Target Gene
Patent: 8,546,143 →
Application: 12/894,018 →
Publication: US 2011/0111493
Compositions and Methods for Inhibiting Expression of a Target Gene
Patent: 9,074,213 →
Application: 14/012,994 →
Publication: US 2014/0106450
Compositions and Methods for Inhibiting Expression of a Target Gene
Patent: 9,587,240 →
Application: 14/737,304 →
Publication: US 2015/0353937
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 28, 2016
From: KREUTZER, ROLAND; LIMMER, STEFAN; LIMMER, SYLVIA; HADWIGER, PHILIPP
To: RIBOPHARMA AG
Reel/Frame 038413/0749 →
Change of Name Apr 28, 2016
From: RIBOPHARMA AG
To: ALNYLAM EUROPE AG
Reel/Frame 038558/0064 →
Security Interest Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →